Successful treatment of B-cell lymphoma associated with hemophagocytic syndrome using autologous peripheral blood CD34 positive cell transplantation followed by induction of autologous graft-versus-host disease

Ann Hematol. 2000 Jul;79(7):389-91. doi: 10.1007/s002770000157.

Abstract

A 56-year-old man who presented with persistent high fever and abdominal pain was diagnosed as having a B-cell lymphoma associated with hemophagocytic syndrome (B-LAHS). As post-remission therapy, the patient was treated with high-dose chemoradiotherapy followed by infusion of autologous CD34+ cells that had been isolated from the peripheral blood buffy coat. Cyclosporin and interferon (IFN)-gamma were administered to induce autologous graft-versus-host disease (GVHD). Hematopoietic recovery promptly occurred and skin GVHD developed on day 26 after CD34+ cell transplantation. The patient has been in complete remission without therapy for 20 months since transplant. Autologous CD34+ cell transplantation in combination with induction of autologous GVHD may be efficacious in obtaining a cure for B-LAHS.

Publication types

  • Case Reports

MeSH terms

  • Antigens, CD34 / blood*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation*
  • Histiocytosis, Non-Langerhans-Cell / complications*
  • Histiocytosis, Non-Langerhans-Cell / therapy*
  • Humans
  • Lymphoma, B-Cell / complications*
  • Lymphoma, B-Cell / therapy*
  • Male
  • Middle Aged
  • Transplantation, Autologous

Substances

  • Antigens, CD34